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Abstract
Background: Blood transfusion (BT) can be lifesaving for children; however, monitoring the
quality of BT is important. The current study describes the quality of paediatric BT delivered in two
district hospitals in north-east Tanzania in order to identify areas for quality assurance and
improvement in the administration of BT.
Methods: All 166 children admitted in the paediatric wards and receiving BT through April to June
2007 were prospectively observed. Medical records, request forms and registers in the
laboratories were reviewed to identify blood source, blood screening and indications for BT. BT
was observation before, during and after transfusion process.
Results: Malaria related anaemia accounted for 98% of the BTs. Ninety-two percent of the
children were assessed for paleness. Clinical signs such as difficult breathing and symptoms of
cardiac failure were only assessed in 67% and 15% of the children respectively, prior to the BT
decision. Pre-transfusion haemoglobin and body temperature were recorded in 2/3 of the patients,
but respiratory rate and pulse rate were not routinely recorded. In 40% of BTs, the transfusion
time exceeded the recommended 4 hours.
The zonal blood bank (ZBB) and local donors accounted for 10% and 90% of the blood,
respectively. ABO and RhD typing and screening for HIV and syphilis were undertaken in all
transfused blood. Evidence for hepatitis B or C infection was not checked except in the ZBB.
Conclusion: Criteria for BT are not always fulfilled; time to initiate and complete the transfusion
is often unacceptable long and monitoring of vital signs during BT is poor. Blood from the ZBB was
often not available and BT often depended on local donors which implied lack of screening for
hepatitis B and C. It is recommended that an external supervision system be established to monitor
and evaluate the quality of BT performance in the laboratories as well as in wards.
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Background
Blood transfusion (BT) is one of life-saving treatments
available in paediatric wards in African hospitals but its
use is associated with a number of risks including transfu-
sion reactions, heart failure and transmission of infectious
agents [1,2]. For example a Kenyan study found that up to
2% of transfused blood was HIV-infected due to labora-
tory errors [3].
In spite of these risks many children are transfused with-
out meeting standard criteria for transfusion, the most
important of which are severe anaemia with respiratory
distress or impaired consciousness (symptomatic severe
anaemia), conditions associated with mortality between
20–35% [4].
In children, it is important to minimise delay in transfu-
sion as the majority of deaths occur before BT is started
[5]. If there is a delay of BT for more than 24 hours then
there is probably no additional benefit to transfusion.
During the transfusion children need to be closely moni-
tored for evidence of respiratory distress or transfusions
reactions [6].
A large variation in mortality has been reported among
children transfused in Kenyan district hospitals [7]. It is
likely that this is the result of variations in standards of
care in selecting children for transfusion, screening blood
or administering BT in a timely and safe way. However
very little detail is known about how children are selected
for transfusion and how these children are subsequently
managed in these settings. We conducted this study over a
3 month period to assess how children were transfused
and whether this was in line with current guidelines in 2
hospitals serving populations exposed to high malaria
transmission in North-East (NE) Tanzania.
Methods
Study hospitals
The study was conducted in two district hospitals each
serving predominantly rural populations in a malaria-
endemic area of NE Tanzania. Hospital A had considera-
bly more human and technical resources available than
hospital B, due to an ongoing research programme (hos-
pital A had 10 doctors and 18 nurses working in the pae-
diatric ward while hospital B had 3 doctors and 9 nurses
in its paediatric ward). In 2005 Hospital A and B had 27
and 28 paediatric beds respectively, and 4,266 and 4,447
paediatric admissions. None of the hospital had a fridge
for storing blood in the ward and therefore, locally
donated blood was not stored.
At the time of the study, nationally recommended indica-
tions for transfusion were primarily Hb < 4 g/dl or < 6 g/
dl with respiratory distress. Blood screening recommenda-
tions included ABO and Rh matching and screening for
HIV, syphilis and hepatitis B and C virus [8].
Each hospital had a laboratory to screen and cross match
blood for transfusion. In both hospitals a Hemocue
(201+, Hemocue AB, Ängelholm Sweden) was used to
measure haemoglobin level.
Data collection
Data were collected during the rainy season between mid
April to the end of June, 2007. All children who were
transfused in the paediatric ward during the study period
were included.
Quality indicators of blood transfusion practices were
selected from WHO guidelines [9] and information gath-
ering was as follows; Children who were prescribed for BT
were followed from the start by a research assistant who
was always available (24 hours a day). A questionnaire
recorded the time of decision for blood transfusion (from
the case notes or inquiry with the admitting physician)
and time of starting and stopping the transfusion. Details
of frequency of observations were recorded in most cases
by direct observation supplemented by a review of case
notes. Laboratory data were collected from routine regis-
ters kept in each laboratory supplemented by direct obser-
vation.
For quality control of the transfused blood basing on HIV
status, two millilitres of blood was taken from the remains
in the blood bag after transfusion. Blood was centrifuged
and transported to a research laboratory where samples
were anonymously tested for HIV using Western Blot® test
[10].
Data Analysis
SPSS version 12 was used for data analysis. Before data
analysis, data were double entered in MS Access and data
cleaning was done to ensure maximum accuracy and con-
sistence. Numerical variables were summarised into
median and range. Categorical variables were summarised
using cross tabulation to estimate different proportions,
X2 (and chi-trend) and their respective p-values at 5% (2-
tail) were also estimated. However, the statistical test to
assess for interaction between hospitals was not included.
Ethics
The study was approved by the Ethical Review Committee
of Kilimanjaro Christian Medical Centre. It was author-
ised by the hospital directors of the two study hospitals
and the manager of NE Zone Blood Bank (ZBB) which is
the only blood bank serving health facilities within four
regions of NE Tanzania.
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Results
In the study period the two hospitals had a total of 1037
paediatric admissions, of these 166 (16%) of the children
had a BT (24 of the children at hospital A and the rest at
hospital B). Hundred and one (61%) of the recipients
were boys and 65 (39%) were girls. The ratio between
boys and girls was the same for both hospitals. Twenty-
five (15%) of the children had previously received a BT,
the majority within the last couple of months.
The median age at time of BT was 1.8 (range 0.1 – 5.4)
years for both girls and boys. In hospital A the age of study
participants was significantly lower than in Hospital B
(median 1.5 against 2.1 years, p < 0.01). Malaria associ-
ated with anaemia accounted for 157 (98%) of the BTs,
and only 2% had a diagnosis of marasmus, pneumonia or
burn.
The clinical signs were recorded before making decisions
for BT as shown in Table 1. About 57 (35%) of patients
from hospital B were not measured for haemoglobin (Hb)
before transfusion. However, this was contrary to hospital
A where Hb from all patients was measured before trans-
fusion.
There was a wide variation in Hb recorded values prior to
BT between patients (ranged from 2 g/dl to 8 g/dl). We
also observed the difference in mean Hb before transfu-
sion in the two hospitals. Hospital A have had lower mean
Hb (3.9 g/dl) compared to hospital B (4.7 g/dl). This dif-
ference was statistically significant (p < 0.05). Less than a
quarter, 25 (23%) of the children had Hb < 4 g/dl and 65
(59%) had the Hb between 4 g/dl and 5.9 g/dl. Surpris-
ingly, about 20 (18%) of the children from hospital B had
the Hb ≥ 6 g/dl.
Body temperature was recorded in 112 (68%) of the chil-
dren before, in one child (1%) during and in 23 (14%)
after transfusion. Respiratory rate was counted in 42
(25%) before, 3 (2%) during and in 1 (1%) after transfu-
sion. Blood pressure and pulse rate was only measured in
a total of 4 and 6 children, respectively.
In both hospitals there was a wide range in time between
doctor's decision for a patient to be transfused and the ini-
tiation of transfusion (median 2.7 hour and range 35
minutes – 21 hours). The transfusion time (the time
between starting and finishing blood transfusion) ranged
widely from 2 – 16 hours. In 66 (40%) of the studied
patients, the transfusion time was more than 4 hours.
Four children had unspecific reactions reported during
blood transfusion, and BT was in all cases stopped for a
period and then started again. No evidence for a child
death due to blood reaction or lack of BT.
The mean dose of the amount of blood prescribed to a
patient per kilogramme in the two hospitals was 19.3
(median 20 mls/kg and range 2 – 35 mls/kg). Only 17
(10%) of the children were supplied with blood from the
ZBB and 134 (81%) received blood which was donated
directly either from relatives or family friends. For the
remaining 15 (9%) of the patients there was no informa-
tion on the source of blood.
A total of 13 (8.2%) deaths among the transfused children
occurred on the admission date (all in hospital B) and five
(3%) children were referred to the regional hospital.
Females were three times more likely to die compared to
their males counterpart (Old Ratio = 3.4, 95% CI: 0.9–
15.8). However, this difference was not statistically signif-
icant. Our findings also suggested that, there was no gen-
der difference in Hb levels pre-transfusion (p-value =
0.467).
The ABO Rhesus grouping and compatibility tests were
also reported and documented meticulously in the two
hospital laboratories. Donated blood was screened for
HIV using a Capillus® test and confirmed by Determine®
test. The blood was also screened for syphilis. Surpris-
ingly, none of the studied hospitals performed ELISA or
PCR for HIV screening. Additionally, hepatitis B and C
virus were only screened for ZBB blood. It was evident
from this study that transfused blood was not screened for
malaria. We also observed that packed red blood cells
were not prepared; instead all children in need of blood
Table 1: Clinical signs recorded before blood transfusion
Clinical sign Present
n (%)
Not present
n (%)
Not described whether present or not
n (%)
Cardiac failure/symptom 13 (8) 12 (7) 141 (85)
Hepatomegaly 7 (4) 146 (88) 13 (8)
Respiratory distress 17 (10) 94 (57) 55 (33)
Impaired consciousness 59 (36) 19 (11) 87 (53)
Capillary refill 3 (2) 17 (10) 146 (88)
Dehydration 16 (10) 141 (85) 9 (5)
Pallor 110/36 (66/22)* 7 (4) 13 (8)
*The numerator represents severe pallor and the denominator represents some pallor
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were transfused whole blood. In addition transfused chil-
dren were also given a dose of furosemide to avoid body
fluid overload.
A sub-sample of 77 blood samples (29 samples from hos-
pital A and 48 samples from hospital B) from the used
blood bag were re-tested for HIV using Western Blood®
test. Fortunately, all blood samples tested negative.
Discussion
This study differs from most other existing studies in
developing countries [3,7,11] by focusing on the entire
process of BT. Our results demonstrate that it is important
to improve the quality of blood transfusion. We have no
reason to believe that standards in the two selected hospi-
tals were significantly different from others in the region,
and in fact one of the hospitals (hospital A) has consider-
ably more human and technical resources available
within the paediatric ward than other hospitals in the
area, due to ongoing research activities.
The decision for a BT was either taken by clinical judg-
ment or by measuring the Hb. In a study from Malawi
[12] it was shown that clinical features might provide a
reasonable basis for indicating the need for BT in areas
with poor laboratory setup. However, in our study the
clinical assessment was not optimal, one third of the chil-
dren were not assessed for respiratory distress and 85%
had no information whether cardiac failure was present.
Over a third of transfused children did not have Hb meas-
ured before BT at hospital B, and among patients in whom
pre-transfusion haemoglobin was actually checked 20
(18%) had pre-transfusion haemoglobin level above 6 g/
dl and no additional indications to justify transfusion.
These findings suggest that clinical judgement can exacer-
bate blood supply shortage. The results are similar to
those of Lackritz et al from Kenya [6] where it was judged
that half of the paediatric transfusions could have been
avoided. Therefore, more has to be done in the current
HIV era where there has been focus on ways to avoid HIV
transmission.
Fourteen (8%) children had to wait for more than 6 hours
from the doctor's decision for BT to the actual initiation of
it. The main underlying reason was limited availability of
blood. The later has also been reported by the Global
Database on Blood Safety [2] and Tanzania National
Blood Transfusion Service [13] that shortage of blood sup-
ply is a growing problem, particularly in developing coun-
tries. The delay might increase the risk of dying due to
severe anaemia in children, as most deaths occur within
the first hours after admission [14].
The procedure during the BT was far from optimal; vital
signs (Respiratory rate, Pulse rate or Blood pressure) were
rarely monitored in spite of well recognised hazards of BT
[1]. Poor monitoring of these important vital signs, at
least in hospital B, might be explained by shortage of staff,
however the situation was the same in hospital A with
considerably more staff. Thus, lack of training, guidelines
and or supervision might be the contributing factors.
To our knowledge the actual time for BTs has not been
observed in other studies in Africa. However, long transfu-
sion time increases risk of haemolysis of the transfused
blood as well as delaying the time before a viable Hb level
is restored [9].
As the study was an observational study, the clinicians and
nurses were informed on the aim of the study. Thus, there
might have been a bias and the staff might in fact have
performed better than normal. The investigators inter-
vened and informed the doctor and or nurse on duty
when care was perceived to put a child at risk e.g. long
waiting time for a patient to be transfused, prolonged
blood transfusion and worsening of the child's clinical
condition during blood transfusion. Therefore, the
observed deficiencies of performance must be considered
a minimum.
Malaria was the leading cause of severe anaemia as found
in other studies in the sub-Saharan Africa [15-17], and the
mortality of 8.5% is similar to what previously has been
reported in Kenya [7]. Fifteen percent of the children in
our study have had another BT within the following cou-
ple of months, this emphasizes that children in need of BT
are a vulnerable group, and there is a need to follow them
after discharge.
It was satisfying that all donated blood was tested for HIV,
although only Capillus® test (a rapid HIV test) was used
and routinely performed in the two hospital laboratories.
Using the more sensitive Western Blot® test (a confirma-
tory) on the selected blood samples, no HIV antibody
positive sample was found. However, WHO proposes an
ELISA HIV test [18] to be performed on donated blood.
The limitation for both Capillus® test and the Western
Blot® test is that they identify HIV antibodies and not HIV
antigens; in a high HIV prevalence area, the sero-negative
window during the HIV incubation period may be impor-
tant. Hepatitis B and C virus tests were not performed in
the two hospitals contrary to National Blood Transfusion
Guideline [13].
Our study found that relatives and friends remain a signif-
icant source of blood for transfusion in the two study
areas compared to ZBB blood. However, it is impressive
that the ZBB in only 2 years period in place and its service
has reached most hospitals within four regions in north-
eastern Tanzania. A Chinese study [19] reported that it is
possible to build up a well functioning blood bank system
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within a few years. Though the conditions in Asia are dif-
ferent from Africa the goal might be to use their system in
an adjusted version to establish blood centres in all
regions of the country.
Conclusion
This study confirms many of the findings from other stud-
ies in Africa [3,11,17] however, it adds new knowledge on
the actual performance of the procedures during the proc-
ess of BT. These suggest the need for improvements in
both laboratory procedures and clinical care. In this part
of Tanzania, many of the laboratory problems may be
reduced as the Zonal Transfusion service extends its activ-
ities.
Our study suggests that it is necessary to improve the qual-
ity of BT at all steps within the procedure. Monitoring and
evaluation system has to be in place in the hospital set-
tings. One way forward could be that the Ministry of
Health develops a standardised form that has to be filled
for each BT, and the ZBB bank could be strengthened and
play an important role in the quality control (Table 2).
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